 |
Funding Opportunites - Research
Further details regarding this announcement can be found at:
http://ww5.komen.org/ResearchGrants/FundingOpportunities.html
|
|
Sponsor/Award: |
SUSAN G KOMEN BREAST CANCER FOUNDATION - INVESTIGATOR INITIATED RESEARCH GRANTS - 2010 SUMMER COMPETITION - PRE APPLICATION |
|
|
Grant Amount: |
UP TO $600K OVER THREE YEARS |
|
Deadline: |
Dean's: Contact your Faculty Research Office for deadline details.
Internal: Jun 18, 2010
Sponsor's: Jun 25, 2010
|
|
|
Subject Areas: |
Cancer Therapeutics, Health Disparities, Breast Cancer, Biomarkers, Prevention, Detection, Genetics |
|
Description: |
IIR Grants seek to stimulate exploration of important issues and novel approaches that will lead to reductions in breast cancer incidence and/or mortality within the next decade.
Komen is introducing a new approach to its IIR RFA in an effort to align supported research projects with Komen?s annual strategic objectives and to provide consistency for the research community. Only applications addressing the specific research issues for that year will be accepted; however, it is expected that a broad range of laboratory and clinical investigations will be proposed within each specific annual research issue. The IIR specific research issues for 2010-2011 are: Prevention/Early Detection, Novel Therapeutics and Resistance, Biology of Breast Cancer, Disparities in Breast Cancer Outcomes. A
pplications addressing topics other than those described above as annual research issues will be administratively withdrawn from consideration, and will not be reviewed or scored. |
|
|
Application Details: |
The application process includes two distinct steps: (1) Submission of a pre-application, followed by (2) submission of a full grant application with supporting documentation. Applicants should be aware of two important resources for submitting their application, Komen Grants Access, the online system used for managing the application process, and Komen Grants Help Desk support, which provides both email and telephone assistance with the application process. All pre-applications will be evaluated to assess whether the proposed research is responsive to the specific objectives and research focus of this year's IIR RFA. Investigators must convincingly demonstrate in their clinical impact statement that the proposed research has significant potential to lead to reductions in breast cancer incidence and/or mortality within the next decade. It is the investigators' responsibility to provide a complete pre-application that clearly addresses each element of the responsiveness review. Investigators will be notified about the conclusion of this review by email within four weeks of submitting their pre-application.
Applicants should go to www.KomenGrantsAccess.org and register as a new user or log in using their existing username and password. They should click on "Start a New Application" to begin entering pre-application information.
***Please contact RD&S [Theresa Russelo: trusselo@uwo.ca] for information regarding the "Applicant Signing Official". ****
Once all sections of the pre-application are marked final, the applicant or alternate submitter must submit the pre-application before the deadline.INDIRECT COSTS OF 25% NEED TO BE INCLUDED IN THE BUDGET |
|
NOTE: Letters of Intent and Full Applications are to be processed through Research Development Services for institutional signatures, and are to be accompanied by a completed RDAF form (bearing applicant, Chair and Dean signatures). Requests for Institutional signatures should be received no less than 3 days prior to the posted Sponsor deadline. |
|
Western Contacts: |
Pocock,Katy
Russelo,Theresa M
|
|
|
Sponsor Contacts: |
HELPDESK@KOMENGRANTSACCESS.ORG
5005 LBJ FREEWAY
SUITE 370
DALLAS, Texas, United States
972 855-1600
|